US Stock MarketDetailed Quotes

EDSA Edesa Biotech

Watchlist
  • 1.9056
  • +0.2256+13.43%
Close Jan 2 16:00 ET
6.61MMarket Cap-0.99P/E (TTM)

Edesa Biotech Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
26.31%-4.89M
34.13%-967.04K
52.56%-856.48K
-5.60%-1.66M
21.47%-1.41M
45.95%-6.64M
73.92%-1.47M
40.36%-1.81M
-277.33%-1.57M
44.16%-1.79M
Net income from continuing operations
26.32%-6.17M
44.08%-962.05K
15.96%-1.67M
20.26%-1.86M
28.11%-1.68M
52.28%-8.37M
38.86%-1.72M
65.70%-1.98M
48.91%-2.33M
46.68%-2.33M
Depreciation and amortization
1.41%186.05K
-3.84%44.21K
-38.05%51.42K
66.26%45.4K
65.57%45.03K
55.24%183.47K
58.74%45.97K
180.45%83K
-8.62%27.31K
-8.59%27.2K
Other non cash items
---14.77K
--0
----
----
----
----
----
----
----
----
Change In working capital
85.41%571.07K
53.94%-143.13K
5,772.55%650.81K
-95.34%20.85K
-76.74%42.54K
-89.35%308K
90.58%-310.73K
-100.53%-11.47K
-87.19%447.35K
-65.63%182.85K
-Change in receivables
-36.68%356.34K
148.58%284.84K
4,818.65%555.61K
-596.45%-384.53K
-109.39%-99.59K
-72.24%562.77K
-562.87%-586.36K
106.74%11.3K
-95.26%77.46K
145.01%1.06M
-Change in prepaid assets
-34.62%197.14K
333.14%87.49K
-164.75%-128.32K
139.75%199.3K
-33.02%38.66K
1,646.41%301.5K
-500.89%-37.53K
257.20%198.18K
-70.71%83.13K
130.94%57.72K
-Change in payables and accrued expense
103.16%17.59K
-264.60%-515.45K
201.16%223.52K
-28.14%206.07K
111.06%103.46K
-163.01%-556.27K
109.12%313.16K
-108.99%-220.95K
-81.77%286.77K
-427.21%-935.25K
Cash from discontinued investing activities
Operating cash flow
26.31%-4.89M
34.13%-967.04K
52.56%-856.48K
-5.60%-1.66M
21.47%-1.41M
45.95%-6.64M
73.92%-1.47M
40.36%-1.81M
-277.33%-1.57M
44.16%-1.79M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow
----
----
----
----
--0
----
----
----
----
--0
Financing cash flow
Cash flow from continuing financing activities
-87.74%592.03K
-107.62%-31.44K
-85.70%106K
-72.31%211.73K
-89.50%305.74K
-58.47%4.83M
144,318.53%412.47K
741.23K
-92.65%764.64K
137.02%2.91M
Net issuance payments of debt
---29.53K
--0
--0
----
----
--0
--0
--0
----
----
Net common stock issuance
-83.21%729.39K
--0
-83.40%138.39K
--275.8K
-89.59%315.2K
-63.66%4.35M
403,043.33%483.77K
--833.75K
--0
135.21%3.03M
Proceeds from stock option exercised by employees
--0
--0
--0
----
----
--770.53K
--1
--0
----
----
Net other financing activities
62.23%-107.82K
55.92%-31.44K
65.02%-32.37K
-486.73%-34.56K
91.83%-9.46K
12.99%-285.44K
-17,463.55%-71.31K
---92.52K
97.81%-5.89K
-97.26%-115.72K
Cash from discontinued financing activities
Financing cash flow
-87.74%592.03K
-107.62%-31.44K
-85.70%106.03K
-72.31%211.7K
-89.50%305.74K
-58.47%4.83M
144,318.53%412.47K
--741.23K
-92.65%764.64K
137.02%2.91M
Net cash flow
Beginning cash position
-24.39%5.36M
-68.39%2.04M
-62.53%2.8M
-48.40%4.27M
-24.39%5.36M
-9.55%7.09M
-49.59%6.46M
-52.97%7.47M
40.63%8.27M
-9.55%7.09M
Current changes in cash
-137.95%-4.3M
5.41%-998.47K
29.47%-750.45K
-79.37%-1.45M
-198.22%-1.1M
-175.64%-1.81M
81.25%-1.06M
64.86%-1.06M
-108.09%-807.51K
156.54%1.12M
Effect of exchange rate changes
-133.71%-25.9K
87.34%-5.09K
-116.62%-8.29K
-330.36%-19.7K
-87.76%7.18K
182.63%76.85K
54.99%-40.22K
199.22%49.91K
-62.65%8.55K
146.87%58.61K
End cash Position
-80.65%1.04M
-80.65%1.04M
-68.39%2.04M
-62.53%2.8M
-48.40%4.27M
-24.39%5.36M
-24.39%5.36M
-49.59%6.46M
-52.97%7.47M
40.63%8.27M
Free cash flow
26.31%-4.89M
34.13%-967.04K
52.56%-856.48K
-5.60%-1.66M
21.47%-1.41M
45.98%-6.64M
73.92%-1.47M
40.39%-1.81M
-276.24%-1.57M
44.22%-1.79M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 26.31%-4.89M34.13%-967.04K52.56%-856.48K-5.60%-1.66M21.47%-1.41M45.95%-6.64M73.92%-1.47M40.36%-1.81M-277.33%-1.57M44.16%-1.79M
Net income from continuing operations 26.32%-6.17M44.08%-962.05K15.96%-1.67M20.26%-1.86M28.11%-1.68M52.28%-8.37M38.86%-1.72M65.70%-1.98M48.91%-2.33M46.68%-2.33M
Depreciation and amortization 1.41%186.05K-3.84%44.21K-38.05%51.42K66.26%45.4K65.57%45.03K55.24%183.47K58.74%45.97K180.45%83K-8.62%27.31K-8.59%27.2K
Other non cash items ---14.77K--0--------------------------------
Change In working capital 85.41%571.07K53.94%-143.13K5,772.55%650.81K-95.34%20.85K-76.74%42.54K-89.35%308K90.58%-310.73K-100.53%-11.47K-87.19%447.35K-65.63%182.85K
-Change in receivables -36.68%356.34K148.58%284.84K4,818.65%555.61K-596.45%-384.53K-109.39%-99.59K-72.24%562.77K-562.87%-586.36K106.74%11.3K-95.26%77.46K145.01%1.06M
-Change in prepaid assets -34.62%197.14K333.14%87.49K-164.75%-128.32K139.75%199.3K-33.02%38.66K1,646.41%301.5K-500.89%-37.53K257.20%198.18K-70.71%83.13K130.94%57.72K
-Change in payables and accrued expense 103.16%17.59K-264.60%-515.45K201.16%223.52K-28.14%206.07K111.06%103.46K-163.01%-556.27K109.12%313.16K-108.99%-220.95K-81.77%286.77K-427.21%-935.25K
Cash from discontinued investing activities
Operating cash flow 26.31%-4.89M34.13%-967.04K52.56%-856.48K-5.60%-1.66M21.47%-1.41M45.95%-6.64M73.92%-1.47M40.36%-1.81M-277.33%-1.57M44.16%-1.79M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow ------------------0------------------0
Financing cash flow
Cash flow from continuing financing activities -87.74%592.03K-107.62%-31.44K-85.70%106K-72.31%211.73K-89.50%305.74K-58.47%4.83M144,318.53%412.47K741.23K-92.65%764.64K137.02%2.91M
Net issuance payments of debt ---29.53K--0--0----------0--0--0--------
Net common stock issuance -83.21%729.39K--0-83.40%138.39K--275.8K-89.59%315.2K-63.66%4.35M403,043.33%483.77K--833.75K--0135.21%3.03M
Proceeds from stock option exercised by employees --0--0--0----------770.53K--1--0--------
Net other financing activities 62.23%-107.82K55.92%-31.44K65.02%-32.37K-486.73%-34.56K91.83%-9.46K12.99%-285.44K-17,463.55%-71.31K---92.52K97.81%-5.89K-97.26%-115.72K
Cash from discontinued financing activities
Financing cash flow -87.74%592.03K-107.62%-31.44K-85.70%106.03K-72.31%211.7K-89.50%305.74K-58.47%4.83M144,318.53%412.47K--741.23K-92.65%764.64K137.02%2.91M
Net cash flow
Beginning cash position -24.39%5.36M-68.39%2.04M-62.53%2.8M-48.40%4.27M-24.39%5.36M-9.55%7.09M-49.59%6.46M-52.97%7.47M40.63%8.27M-9.55%7.09M
Current changes in cash -137.95%-4.3M5.41%-998.47K29.47%-750.45K-79.37%-1.45M-198.22%-1.1M-175.64%-1.81M81.25%-1.06M64.86%-1.06M-108.09%-807.51K156.54%1.12M
Effect of exchange rate changes -133.71%-25.9K87.34%-5.09K-116.62%-8.29K-330.36%-19.7K-87.76%7.18K182.63%76.85K54.99%-40.22K199.22%49.91K-62.65%8.55K146.87%58.61K
End cash Position -80.65%1.04M-80.65%1.04M-68.39%2.04M-62.53%2.8M-48.40%4.27M-24.39%5.36M-24.39%5.36M-49.59%6.46M-52.97%7.47M40.63%8.27M
Free cash flow 26.31%-4.89M34.13%-967.04K52.56%-856.48K-5.60%-1.66M21.47%-1.41M45.98%-6.64M73.92%-1.47M40.39%-1.81M-276.24%-1.57M44.22%-1.79M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.